John J. LiPuma

John J. LiPuma

University of Michigan-Dearborn

H-index: 84

North America-United States

About John J. LiPuma

John J. LiPuma, With an exceptional h-index of 84 and a recent h-index of 43 (since 2020), a distinguished researcher at University of Michigan-Dearborn, specializes in the field of Infectious Diseases, Microbiology, Cystic Fibrosis, Microbiome.

His recent articles reflect a diverse array of research interests and contributions to the field:

Prevalence and clinical impact of respiratory viral infections from the STOP2 study of cystic fibrosis pulmonary exacerbations

Source-to-Tap Investigation of the Occurrence of Nontuberculous Mycobacteria in a Full-Scale Chloraminated Drinking Water System

Longitudinal bacterial prevalence in cystic fibrosis airways: Fact and artifact

Investigating the suitability of online flow cytometry for monitoring full-scale drinking water ozone system disinfection effectiveness

Novel Ralstonia species from human infections: improved matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based identification and …

Airway bacterial community composition in persons with advanced cystic fibrosis lung disease

594 Assessing effectiveness of cleaning and disinfection of equipment and environmental surfaces in cystic fibrosis clinics using an adenosine triphosphate assay

Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug‐resistant Burkholderia multivorans

John J. LiPuma Information

University

Position

___

Citations(all)

24584

Citations(since 2020)

7530

Cited By

20077

hIndex(all)

84

hIndex(since 2020)

43

i10Index(all)

250

i10Index(since 2020)

179

Email

University Profile Page

University of Michigan-Dearborn

Google Scholar

View Google Scholar Profile

John J. LiPuma Skills & Research Interests

Infectious Diseases

Microbiology

Cystic Fibrosis

Microbiome

Top articles of John J. LiPuma

Title

Journal

Author(s)

Publication Date

Prevalence and clinical impact of respiratory viral infections from the STOP2 study of cystic fibrosis pulmonary exacerbations

Annals of the American Thoracic Society

Christina S Thornton

Lindsay J Caverly

Linda M Kalikin

Lisa A Carmody

Scott McClellan

...

2024/4

Source-to-Tap Investigation of the Occurrence of Nontuberculous Mycobacteria in a Full-Scale Chloraminated Drinking Water System

bioRxiv

Katherine Shea Dowdell

Sarah C Potgieter

Kirk Olsen

Soojung Lee

Matthew Vedrin

...

2024

Longitudinal bacterial prevalence in cystic fibrosis airways: Fact and artifact

Journal of Cystic Fibrosis

DR VanDevanter

JJ LiPuma

MW Konstan

2024/1/1

Investigating the suitability of online flow cytometry for monitoring full-scale drinking water ozone system disinfection effectiveness

Water Research

Katherine S Dowdell

Kirk Olsen

Ernesto F Martinez Paz

Aini Sun

Jeff Keown

...

2024/4/30

Novel Ralstonia species from human infections: improved matrix-assisted laser desorption/ionization time-of-flight mass spectrometry-based identification and …

Microbiology Spectrum

Stephanie Steyaert

Charlotte Peeters

Anneleen D Wieme

Astrid Muyldermans

Kristof Vandoorslaer

...

2024/4/25

Airway bacterial community composition in persons with advanced cystic fibrosis lung disease

Journal of Cystic Fibrosis

Christina S Thornton

Lisa A Carmody

Linda M Kalikin

Kristopher Opron

Lindsay J Caverly

...

2023/7/1

594 Assessing effectiveness of cleaning and disinfection of equipment and environmental surfaces in cystic fibrosis clinics using an adenosine triphosphate assay

Journal of Cystic Fibrosis

T Shields

M Ansar

K Shah

I Lowell

J Lipuma

...

2023/10/1

Phage therapy in a lung transplant recipient with cystic fibrosis infected with multidrug‐resistant Burkholderia multivorans

Transplant Infectious Disease

Ghady Haidar

Benjamin K Chan

Shu‐Ting Cho

Kailey Hughes Kramer

Hayley R Nordstrom

...

2023/4

Activity of ETX0462 toward Some Burkholderia spp.

Antimicrobial Agents and Chemotherapy

Elise T Zeiser

Scott A Becka

John J LiPuma

Krisztina M Papp-Wallace

2023/1/24

11 Examining antibiotic regimen spectrum and clinical outcomes of pulmonary exacerbation treatment

Journal of Cystic Fibrosis

J Cogen

S Heltshe

D VanDevanter

J Lipuma

N West

...

2023/10/1

Outbreak of Burkholderia multivorans among patients at two acute-care hospitals in California, August 2021–July 2022

Antimicrobial Stewardship & Healthcare Epidemiology

Kiara McNamara

W Wyatt Wilson

Dipesh Solanky

Sophie Jones

Elizabeth Ohlsen

...

2023/6

Burkholderia, Stenotrophomonas, Ralstonia, Cupriavidus, Pandoraea, Brevundimonas, Comamonas, Delftia, and Acidovorax

John J LiPuma

Bart J Currie

Robert W Baird

Peter Vandamme

2023

629 Updates in Burkholderia infection epidemiology in cystic fibrosis

Journal of Cystic Fibrosis

L Caverly

A Bumford

J Krot

L Kalikin

J Lipuma

2023/10/1

Quantifying variation in home spirometry in people with cystic fibrosis during baseline health, and associations with clinical outcomes

Journal of Cystic Fibrosis

Christina S Thornton

Amalia S Magaret

Lisa A Carmody

Linda M Kalikin

Richard H Simon

...

2023/5/26

Assessing the effectiveness of near real-time flow cytometry in monitoring ozone disinfection in a full-scale drinking water treatment plant

medRxiv

Katherine S Dowdell

Kirk Olsen

Ernesto F Martinez Paz

Aini Sun

Jeff Keown

...

2023

705 Awareness and changes in infection prevention and control practices in cystic fibrosis centers associated with the COVID-19 pandemic

Journal of Cystic Fibrosis

M Ansar

J Zhou

T Shields

J Lipuma

L Saiman

...

2023/10/1

Characterizing Biofilm Interactions between Ralstonia insidiosa and Chryseobacterium gleum

Microbiology Spectrum

Andrea Foote

Kristin Schutz

Zirui Zhao

Pauline DiGianivittorio

Bethany R Korwin-Mihavics

...

2023/4/13

Examining the activity of cefepime-taniborbactam against Burkholderia cepacia complex and Burkholderia gladioli isolated from cystic fibrosis patients in the …

Antimicrobial Agents and Chemotherapy

Maria F Mojica

Elise T Zeiser

Scott A Becka

John J LiPuma

David A Six

...

2023/11/15

697 Rationale and development of a cystic fibrosis–specific antibiotic spectrum index as a stewardship initiative

Journal of Cystic Fibrosis

R Somayaji

S Heltshe

D VanDevanter

J Lipuma

J Gerber

...

2023/10/1

Microbial community organization designates distinct pulmonary exacerbation types and predicts treatment outcome in cystic fibrosis

bioRxiv

Stefanie Widder

Kristopher Opron

Lisa A Carmody

Linda M Kalikin

Lindsay J Caverly

...

2023

See List of Professors in John J. LiPuma University(University of Michigan-Dearborn)